Will a patient on lactate-containing peritoneal dialysis (PD) fluid have elevated lactate levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lactate Levels in Patients on Lactate-Containing Peritoneal Dialysis Fluid

Yes, patients on lactate-containing peritoneal dialysis fluid can have elevated serum lactate levels, though the clinical significance of this elevation differs from that in non-dialysis patients. 1, 2

Mechanism and Evidence

  • Absorption of lactate: Peritoneal dialysis (PD) solutions commonly use lactate as a buffer (typically 35-45 mmol/L), which can be absorbed into the bloodstream during dialysis 3, 4

  • Elevation patterns:

    • In stable PD patients, serum lactate levels are typically within normal range during routine care 5
    • However, during acute illness or intercurrent events, PD patients show a higher prevalence of elevated lactate (>2 mmol/L) - observed in 29% of emergency department visits 2
    • D-lactate specifically can be elevated up to 4-fold higher than controls in patients using D-lactate-containing PD fluids 6
  • Energy contribution: Lactate from PD fluid provides 3.62 kcal/g and can contribute significant calories (115-1300 kcal/day) depending on the type and rate of fluids used 3

Clinical Implications

Interpretation of Elevated Lactate

  • Different significance: Elevated lactate in PD patients does not carry the same prognostic significance as in the general population 2

  • Not always indicating shock: In approximately 50% of PD patients with elevated lactate presenting to emergency departments, there were no signs of hemodynamic instability 2

  • Misleading diagnostic trigger: Elevated lactate in PD patients rarely indicates bowel ischemia despite often triggering abdominal CT scans (46.2% of cases with elevated lactate underwent CT, but bowel ischemia was present in only 1 case) 2

Management Considerations

  • Buffer selection:

    • Bicarbonate is preferred over lactate as buffer for dialysis fluids in patients with hemodynamic instability, lactic acidosis, or liver failure 1
    • Bicarbonate/lactate-buffered neutral PD fluid may have beneficial effects on peritoneal preservation 7
  • Nutritional accounting:

    • The calories from lactate in PD fluid should be included when calculating total energy provision to avoid overfeeding 3
    • This is particularly important when using high lactate replacement fluids, which can provide substantial calories 3

Special Considerations

  • Contraindications for lactate-buffered solutions:

    • Severe liver failure
    • Pre-existing lactic acidosis
    • Post-liver transplantation
    • Hemodynamic instability/shock 1, 4
  • Monitoring: In patients using lactate-containing PD fluids who present with acute illness, lactate levels should be interpreted cautiously and not used as the sole indicator of tissue hypoperfusion 2

Remember that elevated lactate in PD patients during acute illness may reflect altered metabolism of absorbed lactate rather than tissue hypoxia, and unnecessary investigations based solely on lactate elevation should be avoided.

References

Guideline

Lactate Use in End-Stage Renal Disease Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Increased Serum Lactate in Peritoneal Dialysis Patients Presenting with Intercurrent Illness.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

High serum D-lactate in patients on continuous ambulatory peritoneal dialysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997

Research

Longer-Period Effects of Bicarbonate/Lactate-Buffered Neutral Peritoneal Dialysis Fluid in Patients Undergoing Peritoneal Dialysis.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.